Pricing Log in Create free account

Rani Therapeutics Holdings, Inc. (RANI) vs Tenaya Therapeutics, Inc. (TNYA)

Rani Therapeutics Holdings, Inc. and Tenaya Therapeutics, Inc. are both Biotechnology companies. Rani Therapeutics Holdings, Inc. and Tenaya Therapeutics, Inc. are of similar size ($94.8M and $91.6M). Tenaya Therapeutics, Inc. has the higher net margin (0.00% vs −597.0%) and the higher return on invested capital (0.00% vs 0.00%). Across the 12 metrics below, Rani Therapeutics Holdings, Inc. leads on 6 and Tenaya Therapeutics, Inc. on 6.

Valuation

Metric RANI TNYA Biotechnology median
P/E n/m n/m 8.50
P/S 23.73 n/m 9.71
P/B 2.50 1.16 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales 16.27 n/m 9.21
Earnings yield (42.19%) (143.24%) (33.15%)
Free cash flow yield (16.98%) (65.32%) (25.50%)

Profitability

Metric RANI TNYA Biotechnology median
Gross margin 100.00% 0.00% 65.16%
Operating margin (652.78%) 0.00% 0.00%
Net margin (596.97%) 0.00% 0.00%
Free cash flow margin (402.83%) 0.00% 0.00%
Return on equity (155.24%) (121.86%) (56.36%)
Return on assets (77.54%) (95.61%) (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric RANI TNYA Biotechnology median
Revenue growth (TTM) 78.73% — 6.02%
EPS growth (last fiscal year) 57.14% 54.96% 30.26%
Revenue growth, 5-year CAGR — — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric RANI TNYA Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 5.31 4.52 4.72
Net debt to EBITDA 1.33 1.19 0.96

Dividend

Metric RANI TNYA Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric RANI TNYA Biotechnology median
Market cap 94.79m 91.57m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack